Back to Screener

Healthcare

Janux Therapeutics, Inc.(JANX)

Live Price

Offline

$14.82

+1.65% today

1Y Change

-38.57%

Window

Jun 27, 2025 โ†’ Jun 18, 2026

Market Cap
$870.00M
Revenue Growth
-5.6%
EPS Growth
-43.0%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 27, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Janux Therapeutics, Inc. (JANX) is a Healthcare stock with a market cap of $870.00M and listed on NASDAQ. The stock last traded around $14.82 and down 38.6% across the available one-year price window (Jun 27, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of -5.6%, EPS growth of -43.0%, a dividend yield of 0.0%. What stands out right now is revenue -5.6%, EPS -43.0%, free cash flow -88.5% with operating margin -881.8% and ROIC -16.0%. Valuation already assumes a fairly strong business story at price/sales 48.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines JANX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

JANX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

JANX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

JANX Max Drawdown

-64.94%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for JANX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -0.51
โ€”
โ€”
Est 4181.8B
โ€”
May 14
โ€”
Feb 26, 26
โœ“
-0.51
Est -0.65
+21.5%
7880.0B
Est 83.3B
+9356.0%
Feb 26
โ€”
Nov 6, 25
โœ“
-0.39
Est -0.60
+35.0%
10000.0B
Est โ€”
โ€”
Nov 6
โ€”
Aug 7, 25
โœ—
-0.55
Est -0.48
-14.6%
โ€”
Est 300.0B
โ€”
Aug 7
โ€”
May 8, 25
โœ“
-0.38
Est -0.43
+11.6%
โ€”
Est 660.0B
โ€”
May 8
โ€”
Feb 27, 25
โœ“
-0.36
Est -0.49
+26.5%
โ€”
Est 1816.2B
โ€”
Feb 27
โ€”
Nov 6, 24
โœ—
-0.51
Est -0.37
-37.8%
439.0B
Est 1495.2B
-70.6%
Nov 6
โ€”
Aug 7, 24
โœ“
-0.11
Est -0.32
+65.6%
8897.0B
Est 1450.0B
+513.6%
Aug 7
โ€”
May 7, 24
โœ“
-0.30
Est -0.35
+14.3%
1252.0B
Est 660.0B
+89.7%
May 7
โ€”
Mar 8, 24
โœ“
-0.25
Est -0.37
+32.4%
2461.0B
Est 740.0B
+232.6%
Mar 8
โ€”
Nov 7, 23
โœ“
-0.25
Est -0.46
+45.6%
2517.0B
Est 590.0B
+326.6%
Nov 7
โ€”
Aug 8, 23
โœ“
-0.42
Est -0.52
+19.2%
1057.0B
Est 875.0B
+20.8%
Aug 8
โ€”
May 9, 23
โœ“
-0.42
Est -0.49
+14.3%
2048.0B
Est 870.0B
+135.4%
May 9
โ€”
Mar 10, 23
โœ“
-0.39
Est -0.45
+13.3%
2845.0B
Est 670.0B
+324.6%
Mar 10
โ€”
Nov 10, 22
โœ“
-0.40
Est -0.51
+21.6%
1813.0B
Est 790.0B
+129.5%
Nov 10
โ€”
Aug 9, 22
โœ—
-0.41
Est -0.37
-10.8%
2365.0B
Est 650.0B
+263.9%
Aug 9
โ€”
May 10, 22
โœ“
-0.32
Est -0.37
+13.5%
1589.0B
Est 810.4B
+96.1%
May 10
โ€”
Mar 18, 22
โœ—
-0.33
Est -0.30
-10.0%
1616.0B
Est 433.3B
+272.9%
Mar 18
โ€”
Nov 9, 21
โœ—
-0.26
Est -0.17
-52.9%
1159.0B
Est 130.0B
+791.5%
Nov 9
โ€”
Aug 10, 21
โœ—
-0.62
Est -0.13
-376.9%
482.0B
Est 482.0B
0.0%
Aug 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar